Streetbeat News

Price Targets

ECPG

JMP Securities analyst David Scharf has reiterated a 'Market Outperform' rating on Encore Capital Gr (NASDAQ:ECPG) and maintained a price target of $61.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:33 pm

ACAD

JMP Securities analyst Jason Butler maintains a Market Outperform rating on ACADIA Pharmaceuticals and raises the price target from $31 to $39.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:32 pm

RRC

Benchmark analyst Subash Chandra maintains a Buy rating on Range Resources (NYSE:RRC) and raises the price target from $32 to $39.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:30 pm

AR

Benchmark analyst Subash Chandra maintains a 'Buy' rating on Antero Resources (NYSE:AR) but lowers the price target from $36 to $32.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:29 pm

CASY

Benchmark analyst John Lawrence has reiterated a 'Buy' rating on Casey's General Stores (NASDAQ:CASY) and maintained a price target of $275.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:28 pm

MRO

Benchmark analyst Subash Chandra maintains a Buy rating on Marathon Oil (NYSE:MRO) but has lowered the price target from $32 to $28.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:27 pm

JD

Benchmark analyst Fawne Jiang maintains a Buy rating on JD.com (NASDAQ:JD) and raises the price target from $72 to $73.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:27 pm

NFLX

Wedbush analyst Michael Pachter has reiterated an Outperform rating on Netflix (NASDAQ:NFLX) and maintained a price target of $475.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:21 pm

PEP

Wedbush analyst Gerald Pascarelli has maintained an Outperform rating on PepsiCo and raised the price target from $200 to $206.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:20 pm

THRX

Wedbush analyst David Nierengarten has maintained an Outperform rating on Theseus Pharmaceuticals (NASDAQ:THRX), but lowered the price target from $24 to $7.

Portfolio Pulse from richadhand@benzinga.com

July 14, 2023 | 12:20 pm